Colorectal Cancer Research

Fight CRC informs and influences the research community to commit more resources to colorectal cancer research, including potential breakthrough projects that lead to increased screening for and better outcomes from treatment.


Fight CRC Medical Experts

Some of the world’s most brilliant minds serve on our Medical Advisory Board (MAB). They donate their time to ensure the resources patients receive are credible and accurate. Some of the leading investigators and leaders working in colorectal cancer research have joined forces with Fight CRC.

Fight CRC Expert Workgroups

Fight CRC brings together scientists, nonprofits, and government agencies from around the world to fund breakthrough colon cancer and rectal cancer research. Serving as unbiased mediators, we bring together a diverse group of leaders who share information to advance colorectal cancer research. From publishing peer-reviewed articles in leading healthcare journals to focusing on cutting edge research across disciplines, Fight CRC’s workgroups explore how we can work together to find a cure.

Funding Research

Our generous donors allow Fight CRC to fund innovative and breakthrough research. We restrict funds for the sole purpose of supporting colon and rectal cancer research initiatives. When you donate to our research fund, 100% of the proceeds support our research efforts. This has led to over $1 million put toward research. Learn more about the research we fund.

Research Advocacy

Fight CRC supports research trailblazers through our Research Advocacy and Training and Support (RATS) Program that empowers and trains survivors, caregivers, and clinicians to participate in every aspect of the research process. Our research advocates sit on some of the leading panels and boards in the country to ensure patients are at the center of all research decisions.

Clinical Trials

Colorectal cancer clinical trials test new treatment options including drug therapy, surgery, radiation, and combination procedures. Before new drugs reach patients enrolled in clinical trials, they go through a multi-phased rigorous laboratory process called preclinical research.